
Reset all filters
01 6Lo Loestrin
02 1Lo Loestrin Fe
03 3Marvelon/Mercilon
04 1Minastrin
05 3Minastrin24
06 9NuvaRing
07 2Nuvaring
08 13YAZ/Yasim/Yasminelle
09 1YAZTM/YasimTM/YasminelleTM
10 2Yaz/Yasim/Yasminelle
Main Therapeutic Indication : Urology
Currency : USD
2020 Revenue in Millions : 356
2019 Revenue in Millions : 0
Growth (%) : 100
Main Therapeutic Indication : Urology
Currency : USD
2021 Revenue in Millions : 437
2020 Revenue in Millions : 356
Growth (%) : 23
Norethindrone Acetate, Ethinyl Estradiol
Main Therapeutic Indication : Sexual Health
Currency : USD
2017 Revenue in Millions : 459
2016 Revenue in Millions : 404
Growth (%) : 14
Ethinyl Estradiol, Norethindrone
Main Therapeutic Indication : Sexual Health
Currency : USD
2017 Revenue in Millions : 61
2016 Revenue in Millions : 327
Growth (%) : -81
Norethindrone Acetate, Ethinyl Estradiol
Main Therapeutic Indication : Sexual Health
Currency : USD
2018 Revenue in Millions : 528
2017 Revenue in Millions : 459
Growth (%) : 15%
Ethinyl Estradiol, Norethindrone
Main Therapeutic Indication : Sexual Health
Currency : USD
2018 Revenue in Millions : 10
2017 Revenue in Millions : 61
Growth (%) : -84%
Norethindrone Acetate, Ethinyl Estradiol
Main Therapeutic Indication : Contraception
Currency : USD
2016 Revenue in Millions : 404
2015 Revenue in Millions : 350
Growth (%) : 15
Ethinyl Estradiol, Norethindrone
Main Therapeutic Indication : Contraception
Currency : USD
2016 Revenue in Millions : 327
2015 Revenue in Millions : 273
Growth (%) : 20
Main Therapeutic Indication : Urology
Currency : USD
2019 Revenue in Millions : 589
2018 Revenue in Millions : 528
Growth (%) : 12